Novartis Recalls Lamisil AT Antifungal Cream Due to Illegible Labeling
Novartis Consumer Health is recalling 3,828 tubes of Lamisil AT antifungal cream because the lot and expiration dates may be illegible.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The hazard is limited to packaging/labeling legibility.
Plain-English summary
Novartis Consumer Health is voluntarily recalling 3,828 tubes of Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, NDC 0067-6171-85. The recall is limited to Lot #10118124 with an expiration date of September 2013.
The recall was initiated because the lot and/or expiration date on the tube may not be legible. This labeling issue prevents consumers from verifying the product's identity and expiration status. The affected product was distributed nationwide.
Consumers who have this specific lot of Lamisil AT should stop using it and contact Novartis Consumer Health for a refund or replacement. The FDA has classified this recall as Class III, indicating that use of or exposure to the product is not likely to cause adverse health consequences.
The recalled product
- Product
- Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85
- Manufacturer
- Novartis Consumer Health
- Category
- Drug — Topical Antifungal
- Hazard
- Affected units
- 3,828
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 10118124
- Exp: Sept 2013
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Novartis Consumer Health
See all →- ModerateNovartis Recalls Benefiber Fiber Supplement Stick Packs Due to Consumer Complaints
FDA (Food) · 2014-03-05
- ModerateNovartis Recalls Theraflu Severe Cold & Cough Powder Packets for Foreign Substances
FDA (Drugs) · 2014-01-29
- HighNovartis Recalls Theraflu Powder Packets Due to Foreign Substance Presence
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls NeoCitran Extra Strength Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls Theraflu Exte Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02